ÂÜÀòÂÒÂ×

Roy Hardiman is our Chief Business Officer and general counsel, with over 30 years of business development, legal, alliance management and strategic experience in the biopharmaceutical field. Prior to joining Alumis, he was Chief Business Officer of Principia Biopharma where he negotiated Principia’s core collaborations with Sanofi and AbbVie. Roy spent almost two decades at Genentech where he was one of Genentech’s lead negotiators, with personal accountability for the legal and alliance aspects of Genentech’s relationship with Roche. Roy’s roles at Genentech included vice president of alliance management, vice president of corporate law, and director and Far East representative for business development. Prior to joining Genentech, Roy was an attorney with Morrison-Foerster. Roy received his BA in pharmacology and MA in biology (biochemistry/molecular biology emphasis) from University of California, Santa Barbara, and his JD from University of California, Los Angeles School of Law, and serves on the Board of Trustees of the University of California, Santa Barbara Foundation.